First Choice Healthcare Solutions, Inc. filed a Form 10-Q with the SEC on November 13, 2026, reporting unaudited condensed consolidated financial results for the quarterly and nine-month periods ended September 30, 2026.

Key Highlights

  • Net loss of $19,129,123 was reported for the nine months ended September 30, 2026, compared to a net loss of $3,500,214 for the same period in 2025, according to the filing.
  • Net revenue was $0 for both the three and nine months ended September 30, 2026, down from $230 and $5,686 in the comparable 2025 periods, respectively.
  • Interest expense, net totaled $17,369,765 for the nine months ended September 30, 2026, compared to $2,143,153 in the nine months ended September 30, 2025.
  • Accumulated deficit reached $93,872,190 as of September 30, 2026, up from $74,743,067 as of December 31, 2025.
  • Total stockholders' deficit was $(11,595,833) as of September 30, 2026, compared to $(39,528,075) as of December 31, 2025.
  • Notes payable declined to $9,596,974 as of September 30, 2026, from $27,177,660 as of December 31, 2025, with the filing reflecting a debt conversion of $38,514,152 during the second quarter of 2026.
  • 32,958,288 shares of common stock were issued and outstanding as of November 13, 2026, at a par value of $0.001 per share.

First Choice Healthcare Solutions Reports Zero Revenue and Widening Losses Through September 2026

First Choice Healthcare Solutions, Inc. (OTC:FCHS), a Delaware-incorporated smaller reporting company headquartered at 95 Bulldog Blvd, Suite 202, Melbourne, Florida, filed its quarterly report covering the period ended September 30, 2026. The company reported no net revenue for either the three or nine months ended September 30, 2026, according to the filing. This compares to net revenue of $230 for the three months and $5,686 for the nine months ended September 30, 2025.

The filing disclosed a net loss of $10,681,880 for the three months ended September 30, 2026, versus a net loss of $1,462,885 for the same quarter in 2025. For the nine months ended September 30, 2026, the net loss was $19,129,123, compared to $3,500,214 in the prior-year nine-month period. The filing attributed a substantial portion of the loss to interest expense, net, which reached $9,983,985 for the three months and $17,369,765 for the nine months ended September 30, 2026. Total operating expenses for the nine-month period were $1,957,683, with selling, general and administrative expenses of $1,256,007 representing the largest single component.

The balance sheet as of September 30, 2026, showed total assets of $2,079,216 against total liabilities of $13,675,048, all of which were classified as current. Cash and cash equivalents stood at $135,212, up from $5,896 at December 31, 2025. The filing also noted that Series C and Series E Convertible Preferred Stock were issued during the period, with 23,707 and 23,401 shares outstanding, respectively, as of September 30, 2026, where none had been outstanding at December 31, 2025. The basic and diluted net loss per common share for the nine months ended September 30, 2026, was $(0.58), compared to $(0.11) for the same period in 2025.

What Was Disclosed

First Choice Healthcare Solutions filed a 10-Q for the quarter ended September 30, 2026, disclosing zero revenue, a nine-month net loss of $19,129,123, an accumulated deficit of $93,872,190, and significant preferred stock issuances and debt conversion activity during the period.